Here are five notes:
1. On Feb. 8, StemCells will present at the 2016 BIO CEO Conference at the Waldorf Astoria in New York City.
2. During BIO’s CEO Conference earlier this year, BIO recognized StemCells as the most innovative public company and awarded StemCells the 2016 “Buzz of BIO” in the public company category.
3. StemCells will present at Source Capital Group’s 2016 Disruptive Growth and Healthcare Conference on Feb. 18. at Convene Conference Center in New York City.
4. StemCells will upload a live webcast of the presentation on the company’s website.
5. The company is in the clinical development stage of its HuCNS-SC platform technology. The technology is a possible treatment for patients suffering from a chronic spinal cord injury.
More articles on spine:
8 things for spine surgeons to know for Thursday — Jan. 28, 2016
University Hospitals unveils Avon Rehabilitation Hospital that includes spine injury services: 5 notes
How the Bryan cervical disc faired after 10 years in China: 6 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.